Supplier· Ecuador· Activity through Jul 2026

Glaxosmithkline Ecuador S a

EC-RUC-1790717658001-33897In the source: GLAXOSMITHKLINE ECUADOR S A
Create and download this entity’s chart
Source records
3
Sources
1

Observed volume

3 processes

3 source rows in SERCOP open contracting releases.

Latest activity

Jul 2026

2 records in the period.

Latest comparable change

+1 processes

Jun 2026 → Jul 2026 (+100%)

Leading buyer by amount

Hospital de Especialidades - Teodoro Maldonado Carbo

82.4% of observed USD amount; top three 100%.

History

Historical series by source

2 independent series

Relationships

Top counterparties in the records

Ranked by shared record count, without adding different currencies.

Relationship concentration

Reliance on leading counterparties

Each currency is calculated separately. A high share may reflect specialization, scale, or source coverage and is not by itself evidence of misconduct.

Recent activity

Latest published records

Ordered by the most relevant award, publication, or event date in each source. An identical event published by multiple lifecycle sources is shown once and retains every source in the first column. This does not claim the activity happened today.

SourceAward datePublication dateTitleBuyerStatusAmountCurrency
SERCOP open contracting releasesJul 31, 2026Aug 15, 2026SIE-HTMC-2026-084-2810Hospital de Especialidades - Teodoro Maldonado Carboactive$64,377USD
SERCOP open contracting releasesJul 17, 2026Aug 14, 2026SIE-HTMC-2026-078-2810Hospital de Especialidades - Teodoro Maldonado Carboactive$22,172USD
SERCOP open contracting releasesJun 18, 2026Jul 25, 2026SIE-CMFIEDM-2026-020-748941Centro Medico Familiar Integral y Especialidades, Dialisis la Mariscalactive$18,536USD

Entity monitoring

Monitor Glaxosmithkline Ecuador S a

Get an email when linked records change. Alerts make clear that a change may be new activity, broader coverage, or a source correction.

Coverage and provenance

Sources contributing to this profile

This profile consolidates source keys within one country and role only through exact identifiers or an unambiguous normalized legal name. Currencies and unit scales remain separate; similar names are not assumed to be the same organization.